相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling
Lei Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
STAT1 drives M1 microglia activation and neuroinflammation under hypoxia
Elena Butturini et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
Rachael M. Zemek et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
Hailun Zheng et al.
MOLECULAR CARCINOGENESIS (2019)
Targeting Metabolic-Redox Circuits for Cancer Therapy
Kui Wang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Immunoprecipitation methods to identify S-glutathionylation in target proteins
Elena Butturini et al.
METHODSX (2019)
Cystathionine Promotes the Proliferation of Human Astrocytoma U373 Cells
Halina Jurkowska et al.
ANTICANCER RESEARCH (2018)
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Wusheng Xiao et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer
Wanlu Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway
Mingyue Li et al.
BIOCHEMICAL PHARMACOLOGY (2018)
A new xanthatin analogue 1 beta-hydroxyl-5 alpha-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma
Xin-Yi Fang et al.
BIOCHIMIE (2018)
α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells
Dongdong Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
被撤回的出版物: Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer (Retracted article. See vol. 111, pg. 2196, 2020)
Kaili Liu et al.
CANCER SCIENCE (2018)
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang et al.
CELL METABOLISM (2018)
S-glutathionylation exerts opposing roles in the regulation of STAT1 and STAT3 signaling in reactive microglia
Elena Butturini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγl/Src-mediated paxillin hyperphosphorylation
R. Montone et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hueser et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
Disulfide bond based polymeric drug carriers for cancer chemotherapy and relevant redox environments in mammals
Pei Zhang et al.
MEDICINAL RESEARCH REVIEWS (2018)
Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
Man Liu et al.
MOLECULES (2018)
Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway
Hua Li et al.
ONCOLOGY LETTERS (2018)
STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
Lei Wang et al.
CANCER SCIENCE (2018)
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
Bodo Haas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ophiopogonin D, a Steroidal Glycoside Abrogates STAT3 Signaling Cascade and Exhibits Anti-Cancer Activity by Causing GSH/GSSG Imbalance in Lung Carcinoma
Jong Hyun Lee et al.
CANCERS (2018)
TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/Twist1 Pathway in Non-Small-Cell Lung Carcinoma
Yintao Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Continuous overexpression of thioredoxin 1 enhances cancer development and does not extend maximum lifespan in male C57BL/6 mice
Lisa C. Flores et al.
PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES (2018)
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms
Raajit K. Rampai et al.
BLOOD ADVANCES (2018)
Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway
Li Cui et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor
Hyo Jin Kang et al.
ONCOTARGET (2017)
Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor
Xin Cheng et al.
ONCOTARGET (2017)
Control of the NADPH supply for oxidative stress handling in cancer
Rafael Moreno-Sanchez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Dehydrocostus Lactone Suppresses Proliferation of Human Chronic Myeloid Leukemia Cells Through Bcr/Abl-JAK/STAT Signaling Pathways
Hong Cai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics
Ahmad A. Zulkifli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells
Yujiro Tsujita et al.
ONCOLOGY REPORTS (2017)
Santamarine Inhibits NF-κB and STAT3 Activation and Induces Apoptosis in HepG2 Liver Cancer Cells via Oxidative Stress
Tahir Mehmood et al.
JOURNAL OF CANCER (2017)
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
Zan-Hui Jia et al.
PLOS ONE (2017)
Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species
Mingyue Li et al.
SCIENTIFIC REPORTS (2017)
Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
Amara Maryam et al.
SCIENTIFIC REPORTS (2017)
Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells
Farha Arakkaveettil Kabeer et al.
INTEGRATIVE MEDICINE RESEARCH (2017)
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
M. Buchert et al.
ONCOGENE (2016)
Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function
Elena Butturini et al.
BIOCHEMICAL JOURNAL (2016)
A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice
Jia-Hua Feng et al.
MOLECULAR CANCER THERAPEUTICS (2016)
IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer
Guibin Zhao et al.
ONCOLOGY REPORTS (2016)
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
E. M. Dijkgraaf et al.
ANNALS OF ONCOLOGY (2015)
Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma
Kenshi Suzuki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
Robert Z. Orlowski et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2
Xaioyan Xuan et al.
MOLECULAR BIOLOGY REPORTS (2015)
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation
Elena Butturini et al.
ACS CHEMICAL BIOLOGY (2014)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model
Toshi Murakami et al.
LUNG CANCER (2014)
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
A. Tagde et al.
BLOOD CANCER JOURNAL (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Protective Role of Methionine Sulfoxide Reductase A Against Ischemia/Reperfusion Injury in Mouse Kidney and Its Involvement in the Regulation of Trans-Sulfuration Pathway
Jee In Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Peter M. Voorhees et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Generation of Prostate Tumor-Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling
Yi Qu et al.
CANCER RESEARCH (2013)
A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells
Chi-Tai Yeh et al.
CARCINOGENESIS (2013)
Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs
Elena Butturini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Sesquiterpenoids Lactones: Benefits to Plants and People
Martin Chadwick et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Elizabeth R. Plimack et al.
ONCOLOGIST (2013)
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
Qing Cao et al.
PHYSIOLOGICAL GENOMICS (2013)
Role of Glutathione in Cancer Progression and Chemoresistance
Nicola Traverso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Evaluation of STAT3 Signaling in ALDH plus and ALDH+/CD44+/CD24-Subpopulations of Breast Cancer Cells
Li Lin et al.
PLOS ONE (2013)
Alantolactone Induces Apoptosis in HepG2 Cells through GSH Depletion, Inhibition of STAT3 Activation, and Mitochondrial Dysfunction
Muhammad Khan et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells
Hanhui Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
K. Fizazi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function
Jian-Xin Lin et al.
IMMUNITY (2012)
Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells
Muhammad Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Concetta Conticello et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The SOCS boxuAdapting proteins for ubiquitination and proteasomal degradation
Edmond M. Linossi et al.
IUBMB LIFE (2012)
(-)-Epigallocatechin Gallate Induces Fas/CD95-Mediated Apoptosis through Inhibiting Constitutive and IL-6-Induced JAK/STAT3 Signaling in Head and Neck Squamous Cell Carcinoma Cells
Hui-Yi Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Regulatory Control or Oxidative Damage? Proteomic Approaches to Interrogate the Role of Cysteine Oxidation Status in Biological Processes
Jason M. Held et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling Is Redox-Sensitive
Carlos Zgheib et al.
PLOS ONE (2012)
Intestinal redox biology and oxidative stress
Magdalena L. Circu et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Phase 2 Study of Dasatinib in the Treatment of Head and Neck Squamous Cell Carcinoma
Heather D. Brooks et al.
CANCER (2011)
Potent and Selective Phosphopeptide Mimetic Prodrugs Targeted to the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3
Pijus K. Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
Mei Zhao et al.
LUNG CANCER (2011)
Two Naturally Occurring Terpenes, Dehydrocostuslactone and Costunolide, Decrease Intracellular GSH Content and Inhibit STAT3 Activation
Elena Butturini et al.
PLOS ONE (2011)
Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma
Ying Liu et al.
PLOS ONE (2011)
The Anti-Interleukin-6 Antibody Siltuximab Down-Regulates Genes Implicated inTumorigenesis in Prostate Cancer Patients From a Phase I Study
Jayaprakash Karkera et al.
PROSTATE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3
Li Li et al.
CANCER RESEARCH (2010)
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer
P. W. Gout et al.
Current Oncology (2010)
What made sesquiterpene lactones reach cancer clinical trials?
Akram Ghantous et al.
DRUG DISCOVERY TODAY (2010)
Redox sensing: orthogonal control in cell cycle and apoptosis signalling
D. P. Jones
JOURNAL OF INTERNAL MEDICINE (2010)
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Jinbo Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
B. Fuh et al.
BRITISH JOURNAL OF CANCER (2009)
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Marcin Kortylewski et al.
CANCER CELL (2009)
Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities
Steven Fletcher et al.
CHEMBIOCHEM (2009)
S-Glutathionylation Impairs Signal Transducer and Activator of Transcription 3 Activation and Signaling
Yi Xie et al.
ENDOCRINOLOGY (2009)
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
Mustafa Benekli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Regulation of glutathione synthesis
Shelly C. Lu
MOLECULAR ASPECTS OF MEDICINE (2009)
Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Po-Lin Kuo et al.
MOLECULAR CANCER THERAPEUTICS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Molecular mechanisms and clinical implications of reversible protein S-glutathionylation
John J. Mieyal et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Molecular mechanisms and potential clinical significance of S-glutathionylation
Isabella Dalle-Donne et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Crystal structure of unphosphorylated STAT3 core fragment
Zhiyong Ren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Thiol chemistry and specificity in redox signaling
Christine C. Winterbourn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
WP1066 disrupts janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells
Alessandra Ferrajoli et al.
CANCER RESEARCH (2007)
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Xulong Zhang et al.
BMC CANCER (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction
Svetlana A. Tsareva et al.
NEOPLASIA (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA
Anke Bachelier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Evaluation of potential Stat3-regulated genes in human breast cancer
FC Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation
R Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach:: implications for cancer therapy
SC Xi et al.
ONCOGENE (2005)
Stat3 dimerization regulated by reversible acetylation of a single lysine residue
ZL Yuan et al.
SCIENCE (2005)
Glutathione metabolism and its implications for health
GY Wu et al.
JOURNAL OF NUTRITION (2004)
Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions
JY Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
SJ Park et al.
JOURNAL OF IMMUNOLOGY (2004)
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
B He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation
J Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of glutathione: implication in redox and detoxification
A Pastore et al.
CLINICA CHIMICA ACTA (2003)
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
PL Leong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Regulation of JAK-STAT signalling in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Oxidative stress-mediated apoptosis - The anticancer effect of the sesquiterpene lactone parthenolide
J Wen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation
T Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation
J Turkson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress
G Waris et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Functional importance of Stat3 tetramerization in activation of the α2-macroglobulin gene
XK Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells
J Heilmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
FQ Schafer et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
STAT proteins: novel molecular targets for cancer drug discovery
J Turkson et al.
ONCOGENE (2000)
In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa
JY Cho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)